C
CNS PHARMACEUTICALS INC
NASDAQ: CNSP (CNS Pharmaceuticals, Inc.)
最近更新时间: 13小时之前5.11
-0.01 (-0.20%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | CNS Pharmaceuticals, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-2.0
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -1.5 |
| 平均 | -2.00 |
|
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 0.21% |
| 机构持股比例 | 1.17% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Barrett & Company, Inc. | 30 Jun 2026 | 8 |
| Danske Bank A/S | 30 Jun 2026 | 1 |
| Sound Income Strategies, Llc | 30 Jun 2026 | 0 |
| Mai Capital Management | 30 Jun 2026 | 0 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合